Seroquel and Dyspnea exertional - a phase IV clinical study of FDA data
Dyspnea exertional is found among people who take Seroquel, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Seroquel and have Dyspnea exertional. It is created by eHealthMe based on reports of 106,172 people who have side effects when taking Seroquel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
106,172 people reported to have side effects when taking Seroquel.
Among them, 169 people (0.16%) have Dyspnea exertional.
What is Seroquel?
Seroquel has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. eHealthMe is studying from 112,367 Seroquel users for its effectiveness, alternative drugs and more.
What is Dyspnea exertional?
Dyspnea exertional is found to be associated with 1,637 drugs and 895 conditions by eHealthMe.
Number of Seroquel and Dyspnea exertional reports submitted per year:
Time on Seroquel when people have Dyspnea exertional *:
Gender of people who have Dyspnea exertional when taking Seroquel*:
Age of people who have Dyspnea exertional when taking Seroquel *:
Common drugs people take besides Seroquel *:
Common side effects people have besides Dyspnea exertional *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Seroquel and have Dyspnea exertional?Check whether Dyspnea exertional is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
- Shah Z, Londhe V, "Influence of various media on the dissolution profiles of immediate-release quetiapine tablets in India", Dissolution Technologies, 2016 Feb .
Alternative drugs to, pros and cons of Seroquel:
- Seroquel (112,367 reports)
Dyspnea exertional treatments and more:
- Dyspnea exertional (38,164 reports)
COVID vaccines that are related to Dyspnea exertional:
- Dyspnea exertional in Moderna COVID Vaccine
- Dyspnea exertional in Pfizer BioNTech Covid Vaccine
- Dyspnea exertional in Johnson and Johnson Covid Vaccine
How severe was Dyspnea exertional and when was it recovered:
Expand to all the drugs that have ingredients of quetiapine fumarate:
Common drugs associated with Dyspnea exertional:
All the drugs that are associated with Dyspnea exertional:
- Dyspnea exertional (1,637 drugs)
Common conditions associated with Dyspnea exertional:
All the conditions that are associated with Dyspnea exertional:
- Dyspnea exertional (895 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on quetiapine fumarate (the active ingredients of Seroquel) and Seroquel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.